Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Exhaustion-associated regulatory regions in CD8+ tumor-infiltrating T cells.

Mognol GP, Spreafico R, Wong V, Scott-Browne JP, Togher S, Hoffmann A, Hogan PG, Rao A, Trifari S.

Proc Natl Acad Sci U S A. 2017 Mar 28;114(13):E2776-E2785. doi: 10.1073/pnas.1620498114. Epub 2017 Mar 10.

2.

Dynamic Changes in Chromatin Accessibility Occur in CD8+ T Cells Responding to Viral Infection.

Scott-Browne JP, López-Moyado IF, Trifari S, Wong V, Chavez L, Rao A, Pereira RM.

Immunity. 2016 Dec 20;45(6):1327-1340. doi: 10.1016/j.immuni.2016.10.028. Epub 2016 Dec 6.

3.

Approaches to Detect microRNA Expression in T Cell Subsets and T Cell Differentiation.

Monticelli S, Äijö T, Trifari S.

Methods Mol Biol. 2017;1514:153-172.

PMID:
27787800
4.

Control of Foxp3 stability through modulation of TET activity.

Yue X, Trifari S, Äijö T, Tsagaratou A, Pastor WA, Zepeda-Martínez JA, Lio CW, Li X, Huang Y, Vijayanand P, Lähdesmäki H, Rao A.

J Exp Med. 2016 Mar 7;213(3):377-97. doi: 10.1084/jem.20151438. Epub 2016 Feb 22.

5.

MicroRNA-directed program of cytotoxic CD8+ T-cell differentiation.

Trifari S, Pipkin ME, Bandukwala HS, Äijö T, Bassein J, Chen R, Martinez GJ, Rao A.

Proc Natl Acad Sci U S A. 2013 Nov 12;110(46):18608-13. doi: 10.1073/pnas.1317191110. Epub 2013 Oct 25. Erratum in: Proc Natl Acad Sci U S A. 2014 Feb 4;111(5):2047.

6.

Functional studies on the IBD susceptibility gene IL23R implicate reduced receptor function in the protective genetic variant R381Q.

Pidasheva S, Trifari S, Phillips A, Hackney JA, Ma Y, Smith A, Sohn SJ, Spits H, Little RD, Behrens TW, Honigberg L, Ghilardi N, Clark HF.

PLoS One. 2011;6(10):e25038. doi: 10.1371/journal.pone.0025038. Epub 2011 Oct 12.

7.

Human IL-25- and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161.

Mjösberg JM, Trifari S, Crellin NK, Peters CP, van Drunen CM, Piet B, Fokkens WJ, Cupedo T, Spits H.

Nat Immunol. 2011 Sep 11;12(11):1055-62. doi: 10.1038/ni.2104.

PMID:
21909091
8.

Regulation of cytokine secretion in human CD127(+) LTi-like innate lymphoid cells by Toll-like receptor 2.

Crellin NK, Trifari S, Kaplan CD, Satoh-Takayama N, Di Santo JP, Spits H.

Immunity. 2010 Nov 24;33(5):752-64. doi: 10.1016/j.immuni.2010.10.012. Epub 2010 Nov 4.

9.

IL-22-producing CD4+ T cells: middle-men between the immune system and its environment.

Trifari S, Spits H.

Eur J Immunol. 2010 Sep;40(9):2369-71. doi: 10.1002/eji.201040848.

10.

Revertant T lymphocytes in a patient with Wiskott-Aldrich syndrome: analysis of function and distribution in lymphoid organs.

Trifari S, Scaramuzza S, Catucci M, Ponzoni M, Mollica L, Chiesa R, Cattaneo F, Lafouresse F, Calvez R, Vermi W, Medicina D, Castiello MC, Marangoni F, Bosticardo M, Doglioni C, Caniglia M, Aiuti A, Villa A, Roncarolo MG, Dupré L.

J Allergy Clin Immunol. 2010 Feb;125(2):439-448.e8. doi: 10.1016/j.jaci.2009.11.034.

PMID:
20159256
11.

Human NKp44+IL-22+ cells and LTi-like cells constitute a stable RORC+ lineage distinct from conventional natural killer cells.

Crellin NK, Trifari S, Kaplan CD, Cupedo T, Spits H.

J Exp Med. 2010 Feb 15;207(2):281-90. doi: 10.1084/jem.20091509. Epub 2010 Feb 8.

12.

Identification of a human helper T cell population that has abundant production of interleukin 22 and is distinct from T(H)-17, T(H)1 and T(H)2 cells.

Trifari S, Kaplan CD, Tran EH, Crellin NK, Spits H.

Nat Immunol. 2009 Aug;10(8):864-71. doi: 10.1038/ni.1770. Epub 2009 Jul 5.

PMID:
19578368
13.

Current understanding of the Wiskott-Aldrich syndrome and prospects for gene therapy.

Trifari S, Marangoni F, Scaramuzza S, Aiuti A, Roncarolo MG, Dupré L.

Expert Rev Clin Immunol. 2007 Mar;3(2):205-15. doi: 10.1586/1744666X.3.2.205.

PMID:
20477109
14.

WASP regulates suppressor activity of human and murine CD4(+)CD25(+)FOXP3(+) natural regulatory T cells.

Marangoni F, Trifari S, Scaramuzza S, Panaroni C, Martino S, Notarangelo LD, Baz Z, Metin A, Cattaneo F, Villa A, Aiuti A, Battaglia M, Roncarolo MG, Dupré L.

J Exp Med. 2007 Feb 19;204(2):369-80. Epub 2007 Feb 12.

15.

Defective Th1 cytokine gene transcription in CD4+ and CD8+ T cells from Wiskott-Aldrich syndrome patients.

Trifari S, Sitia G, Aiuti A, Scaramuzza S, Marangoni F, Guidotti LG, Martino S, Saracco P, Notarangelo LD, Roncarolo MG, Dupré L.

J Immunol. 2006 Nov 15;177(10):7451-61.

16.

Efficacy of gene therapy for Wiskott-Aldrich syndrome using a WAS promoter/cDNA-containing lentiviral vector and nonlethal irradiation.

Dupré L, Marangoni F, Scaramuzza S, Trifari S, Hernández RJ, Aiuti A, Naldini L, Roncarolo MG.

Hum Gene Ther. 2006 Mar;17(3):303-13.

PMID:
16544979
17.

Lentiviral vector-mediated gene transfer in T cells from Wiskott-Aldrich syndrome patients leads to functional correction.

Dupré L, Trifari S, Follenzi A, Marangoni F, Lain de Lera T, Bernad A, Martino S, Tsuchiya S, Bordignon C, Naldini L, Aiuti A, Roncarolo MG.

Mol Ther. 2004 Nov;10(5):903-15.

18.

Wiskott-Aldrich syndrome protein regulates lipid raft dynamics during immunological synapse formation.

Dupré L, Aiuti A, Trifari S, Martino S, Saracco P, Bordignon C, Roncarolo MG.

Immunity. 2002 Aug;17(2):157-66.

19.

Head-to-tail oligomerization of calsequestrin: a novel mechanism for heterogeneous distribution of endoplasmic reticulum luminal proteins.

Gatti G, Trifari S, Mesaeli N, Parker JM, Michalak M, Meldolesi J.

J Cell Biol. 2001 Aug 6;154(3):525-34.

Supplemental Content

Loading ...
Support Center